Future treatments for Insulin Resistance
๐งช New Pills for Insulin Resistance: What’s Coming Soon
Doctors and scientists are working hard on new ways to treat insulin resistance—a condition that makes it harder for your body to control blood sugar and can lead to type 2 diabetes. One exciting type of medicine is called a GLPโ1 receptor agonist. These medications help your body make more insulin, control appetite, and lower blood sugar.
Until recently, GLPโ1s were only given as shots. But now, new pills are being tested—and they might make treatment easier and more comfortable.
๐ What’s New in the Pipeline?
Here are 3 pills being studied right now:
- Orforglipron (by Eli Lilly)
- A daily pill that helps with blood sugar and weight loss
- In big studies, it helped people lose weight and lower their A1C (a blood sugar test)
- May be available by late 2025 or early 2026
- Oral Wegovy (Semaglutide by Novo Nordisk)
- Already used as a shot, but now being made as a pill
- Could help people with obesity and insulin resistance
- The FDA is reviewing it now, and we might see it by the end of 2025
- VK2735 (by Viking Therapeutics)
- This pill targets two hormones instead of just one
- Early tests showed it helped people lose weight faster
- More testing is still happening in 2025
๐ Why It Matters
- These new pills could make insulin resistance easier to treat—no needles needed
- They may help people lose weight, feel better, and prevent diabetes
- Doctors will have more options to personalize care based on your needs
Bottom Line:
New treatments are on the way—and they could make a big difference for people with insulin resistance. Keep an eye out for FDA approvals later this year!
